Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Cognitive and Behavioral Predictors of Light Therapy Use

  • Kathryn A. Roecklein ,

    kroeck@pitt.edu

    Affiliation Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  • Julie A. Schumacher,

    Affiliation Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, Mississippi, United States of America

  • Megan A. Miller,

    Affiliation Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

  • Natalie C. Ernecoff

    Affiliation Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America

Cognitive and Behavioral Predictors of Light Therapy Use

  • Kathryn A. Roecklein, 
  • Julie A. Schumacher, 
  • Megan A. Miller, 
  • Natalie C. Ernecoff
PLOS
x

Abstract

Objective

Although light therapy is effective in the treatment of seasonal affective disorder (SAD) and other mood disorders, only 53–79% of individuals with SAD meet remission criteria after light therapy. Perhaps more importantly, only 12–41% of individuals with SAD continue to use the treatment even after a previous winter of successful treatment.

Method

Participants completed surveys regarding (1) social, cognitive, and behavioral variables used to evaluate treatment adherence for other health-related issues, expectations and credibility of light therapy, (2) a depression symptoms scale, and (3) self-reported light therapy use.

Results

Individuals age 18 or older responded (n = 40), all reporting having been diagnosed with a mood disorder for which light therapy is indicated. Social support and self-efficacy scores were predictive of light therapy use (p's<.05).

Conclusion

The findings suggest that testing social support and self-efficacy in a diagnosed patient population may identify factors related to the decision to use light therapy. Treatments that impact social support and self-efficacy may improve treatment response to light therapy in SAD.

Introduction

Although light therapy is effective in the treatment of seasonal affective disorder (SAD) [1], or Major Depressive Disorder with a Seasonal Pattern, as well as for non-seasonal depression [2], data suggest that only about 41% (24 out of 59) of SAD patients treated successfully with light therapy (LT) report regularly using the treatment in follow-up studies [3]. In another study combining LT and cognitive behavioral therapy (CBT), only 12% (4 out of 34) of individuals with SAD originally treated with LT alone (n = 19) or LT plus CBT (n = 15) used LT during the following winter [4]. These data suggest that the choice to use light therapy is itself a target for intervention. In the present study, we aimed to test whether certain motivational and social cognitive processes may help explain the decision to utilize LT.

Two separate issues exist, 1) LT use during the acute treatment phase, and 2) LT use in subsequent winters. However, similar factors may be associated with LT use in both instances. Among those using LT, only 53% of all those with SAD and 43% of moderate to severe cases meet remission criteria after LT [5]. A more recent light therapy trial found higher remission rates, ranging from 46% to 79%, depending on the stringency of remission criteria [6]. These remission rates compare favorably to remission rates for antidepressant medications, which ranged from 43% to 62% in recent meta-analyses and pooled analyses [7][9]. Maximizing remission rates may require higher rates of adherence to LT prescriptions. Adherence to LT in SAD is lower than hoped, about 41%–60% [3], [10][11] when treatment dropouts are included, and this incomplete adherence may explain the incomplete remission rates. The general literature on medication and medical treatment compliance suggests dose-taking compliance declines as the number of daily doses increases [12], and depression symptoms are associated with noncompliance [13]. Light therapy requires approximately 30–45 minutes a day, which represents a significant time commitment. Factors associated with light therapy use and adherence could be clinically relevant if such factors could be manipulated to help improve treatment outcomes.

In the one study to date assessing possible explanations for not using light therapy, 59 patients originally treated with light therapy were reassessed approximately 9 years later [3]. Among the 56% (n = 33 out of 59) who had discontinued using light therapy, 14% (n = 8) reported they had not had sufficient symptoms, leaving 44% of individuals who did have sufficient symptoms to warrant treatment but chose not to use light therapy. Those individuals reported inconvenience and/or perceived ineffectiveness as reasons for not using light therapy despite having experienced improvement during initial light therapy treatment. To examine further which factors predict light therapy use, we reviewed research on treatment adherence in depression and other similar health conditions in which treatment requires a time commitment.

The Transtheoretical Model [14][15], and Social Cognitive Theory [16] both describe variables that have been identified as important predictors of compliance with treatments such as continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea, a treatment requiring nightly use of a CPAP mask and machine somewhat similar to the daily use required for light therapy [17]. Factors such as self-efficacy and depression symptoms have also been associated with adherence to treatments for depression. The Theory of Planned Behavior hypothesizes that tangible barriers (e.g., access to care), illness barriers (e.g., depression symptoms, concerns about treatment), and psychological barriers (e.g., self-efficacy, stigma) are modifiable and, therefore, targets of interventions to improve adherence to medication treatment of depression [18]. An intervention based on this model that incorporates motivational interviewing, problem solving, and psychoeducation has shown a significant increase in adherence to medications in older adults with depression from baseline across 24 weeks compared to treatment as usual [18].

Although different in their mechanisms of efficacy, homework within the context of psychotherapy has similar duration and daily frequency demands as light therapy. A recent meta-analysis of 23 studies on homework found that homework compliance had a small to medium effect (r = .26) on treatment outcome [19]. Individuals with more severe or longer-lasting symptoms comply less with homework [20]. Variables including motivation, readiness to change, and necessary skills are correlated with homework compliance and treatment outcome in cognitive behavioral therapy for depression [21][22].

The above data on factors associated with adherence to either homework in psychotherapy or medication treatment for depression utilize constructs from multiple theories of behavior change. Fishbein et al. (2001) [23] proposed an integration of social cognition, health belief, and other models and focused on eight shared variables including intention to change behavior, environmental barriers, skills, outcome expectations or attitudes, norms, self-standards, emotion, and self-efficacy. The Fishbein et al. (2001) [23] report focused on AIDS-related health behaviors that may have a similar burden of daily frequency and duration as light therapy. Neimeyer and colleagues (2008) [21] recently reviewed theoretical models appropriate for predicting homework compliance in psychotherapy and found that willingness, as well as motivation and stage of change predicted homework compliance.

Aims of the Study

We hypothesize that the aforementioned variables such as social support, self-efficacy, and treatment credibility will predict use of LT in individuals with SAD or non-seasonal depression. Therefore, the present study sought to collect preliminary data using an anonymous web survey of individuals self-identifying as having been previously diagnosed with a disorder for which light therapy is indicated as a treatment. Specifically, we hypothesize that the decision to use LT in the previous winter would be associated with cognitive, behavioral, and social variables including self-efficacy, outcome expectations, social support, processes of change, knowledge and the degree of perceived treatment credibility. We further hypothesized that LT non-use would be associated with higher frequency of self-reported depression symptoms in the previous winter.

Methods

Participants

Participants were recruited through Internet websites such as online SAD-focused groups and websites for national organizations focused on support for individuals with depression. Participants completed the survey anonymously, and IP addresses were not recorded. Participants were informed that they would not be compensated for participation in order to preserve anonymity, and the survey was estimated to take about 20 minutes to complete. The study was approved and determined to be exempt from Human Subjects Research by the University of Pittsburgh Institutional Review Board, because it involved the use of survey data recorded in such a manner that human subjects cannot be identified, as no identifiers were collected. Written documentation of informed consent was waived to preserve anonymity, although information was given to participants prior to beginning the surveys regarding the duration, content, and focus of the study. Only individuals reporting a diagnosis for which LT is a treatment and those who reported having heard of LT were included in the study.

Questionnaire Construction

Questionnaires specific to light therapy were based on existing measures described below, and were tested for psychometric properties including internal consistency as a measure of reliability and dimensionality as a measure of construct validity. Reliability was assessed with Chronbach's alpha, a measure of the intercorrelation among items in a scale, with the traditional cut off of alpha = 0.70. Scales with Chronbach's alphas that fell within the acceptable range for internal consistency (range: 0.70–0.94) were retained. Dimensionality was measured with confirmatory factor analysis, to determine if each scale is unidimensional as hypothesized, reflecting the degree of variance in the measure due to a single common factor. Principal components extraction with varimax rotation was performed, and all scales except for the knowledge scale were identified as having a single component.

With empirical evidence supporting many constructs reviewed above, some similar constructs were excluded in the present study to reduce participant burden or to address specific research hypotheses. Some measures have no clear interpretation when administered retrospectively (i.e., stage of change, intention). Others, such as attitudes, perceived behavioral control, and social norms may overlap with outcome expectations, self-efficacy, and social support scales, respectively. Therefore, the present study involved modifying a subset of all possible scales including the following existing scales to be appropriate for light therapy for depression: outcome expectations, self-efficacy, social support, knowledge, process of change, and treatment credibility. Construction methods and psychometric test results for each scale are described further below.

Outcome Expectations.

Outcome expectations are beliefs about the efficacy and importance of a given behavior in producing desired outcomes, a construct derived from the social cognitive theory [16], [24]. This scale was modified based on one from Stepnowski et al. (2002) [17] for CPAP use in sleep apnea, and another from Gyurcsik, Brawley, Spink, Glazebrook, and Anderson (2011) [25] designed to measure outcomes related to arthritis. Three items assessed how effective participants believed regular use of light therapy is for managing mood, fatigue, and sleep, rated on a 5-point Likert scale from “not at all effective” to “extremely effective.” A fourth item assessed how important respondents believed regular use of light therapy is for managing symptoms on a 5-point scale from “not at all important” to “extremely important.” Internal consistency was acceptable (Chronbach's alpha = .84), and factor analysis revealed a single dimension for this light therapy outcome expectations scale.

Self-Efficacy.

Self-efficacy is the belief that one can engage in a given behavior [16]. Our self-efficacy scale was modeled after those used for CPAP therapy [17] and exercise [26]. Previous items such as “I am confident I can participate in exercise when I am tired” and “I am confident I will use CPAP regularly even if I do not feel like it” were revised for light therapy (e.g., “I am confident I can use light therapy regularly even when I don't want to get up early”). Each of 5 items was scored on a 5-point Likert scale from “disagree completely” to “agree completely.” Internal consistency was high (Chronbach's alpha = .94), and factor analysis revealed a single dimension for this light therapy self-efficacy scale.

Social Support.

Social support in this context refers to the utility of support from friends, family, and health care staff in supporting a given behavior change or adherence to a given treatment, and is also derived from the social cognitive theory [16]. The present scale was modeled on those for CPAP [17] and in light of recommendations for the assessment of social support for behavior change [16], [24]. Items such as “I have people in my life who will support me in using CPAP regularly” were revised for light therapy (e.g., “I have people in my life who support me in using light therapy regularly”). Each of the eight items was scored on a 5-point Likert scale from “disagree completely” to “agree completely.” Internal consistency was high (Chronbach's alpha = .94), and factor analysis revealed a single dimension for this light therapy social support scale.

Knowledge.

The social cognitive theory proposes that accurate information provides the basis upon which behavior change will take place, although it is not expected to explain behavior change alone [16]. Knowledge measures the degree of accuracy of information a person has, as this may provide motivation to use a particular treatment. The first knowledge scale for this study was developed based on previously published scales and included twelve true/false questions such as “Light therapy is effective even if the user's eyes are closed” and “Normal household lights are just as effective as light boxes designed for light therapy.” This knowledge scale had a Chronbach's alpha of only. 44 and a multi-factor solution, so it was excluded from analyses. For future studies, this scale will undergo revision to reduce the level of knowledge assessed to a more basic level.

Processes of Change.

The Transtheoretical Model combines theories of behavior change with learning theory to describe stages of motivational readiness to make a change in a given behavior [27]. Because this was a retrospective survey, the processes used to engage in change was measured, instead of the actual stage of behavioral change a given individual is in at the time of assessment. The hypothesis is that progress through the stages occurs on the basis of processes of change, or behaviors and cognitions that promote change such as reading about a particular treatment. Processes of change describe the reasons that motivate change, and the means by which it is achieved, and are associated with actual behavioral change [27]. The current processes of change questionnaire was based on previously published scales for exercise behavior [28], smoking cessation [29], and CPAP for sleep apnea [17]. Each of 20 items was rated on a 5-point Likert scale (i.e., “never,” “seldom,” “occasionally,” “often,” and “repeatedly”). Items include cognitive processes including consciousness raising, dramatic relief, environmental reevaluation, self-reevaluation, and social liberation. The scale also includes behavioral processes of change including counter-conditioning, helping relationships, reinforcement management, self-liberation, and stimulus control. Items such as this stimulus control item were revised from the original examples; “I put things around my home to remind me of exercising” [28], “I remove things from my home that remind me of smoking” [29] and “I put things around my home to remind me to use CPAP” [17], to be appropriate for light therapy (i.e., “I put my light therapy device in a place so that I'll be easily reminded to use it”). Internal consistency was high (Chronbach's alpha = .92), and factor analysis revealed a single dimension for this light therapy processes of change questionnaire.

The Treatment Expectations and Credibility Survey.

A standardized measure of treatment credibility [30] was revised to evaluate expectations, preferences and credibility of LT as a treatment for depression. In the original Borkovec and Nau (1972) [30] measure, participants rated a new therapy intended to reduce public speaking anxiety in five questions on a 10-point Likert scale. The original included questions such as “1. How logical does this type of therapy seem to you?” and “2. How confident would you be that this treatment would be successful in eliminating fear of speaking before a group?” For the present study, we rephrased questions to reflect light therapy for depression, (e.g., 2. “How confident would you be that light therapy would be successful in eliminating depression?”). This is consistent with the treatment expectation evaluation in Michalak et al. (2007) [11] which assessed 4 items: 1) how logical the treatment seems, 2) how confident they are it would be successful, 3) how useful it might be, and 4) how confident they would be in recommending light therapy to a friend. Each of the 5 items on the scale was rated on a 10-point Likert scale from “not at all logical” to “very logical” or “not at all confident” to “very confident.” The resulting scale had acceptable internal consistency (alpha = .74) and a yielded single factor in factor analysis.

Depression Symptom Frequency.

The Center for Epidemiologic Studies Depression Scale (CES-D) [31] is a 20 item self-report depression symptom scale developed by the National Institutes of Mental Health Center for Epidemiologic Studies. Studies have validated the CES-D as a screening tool to detect depression symptoms and to measure change in symptom severity over time [32]. This scale was not re-tested for psychometric properties in the present study, and was used instead of other measures because it does not assess suicidality, which would be difficult to respond to in an anonymous survey conducted on-line. Participants were asked to “Think about the week you felt the most depressed during the past fall-winter season. Below is a list of the ways you may have felt or behaved during that week. Please rate how often you felt the following ways during that particular week, even if you were not depressed last fall or winter.”

Light Therapy Usage.

A series of items assessing the quantity and quality of light therapy usage by self-report were developed for the current study. A meta-analysis by Golden and colleagues (2005) [1] reported that the effective starting “dose” of light therapy ranged from 30 minutes per day to 1–2 hours, depending on the intensity of the light [1]. Participants were asked to estimate the amount of time they used light therapy in the previous winter on both weekday and weekend days, which were combined for a weighted daily average (i.e., weekday min. ×5, plus weekend min. ×2, quantity divided by 7). Because 59.5% of the sample reported not using LT in the previous winter, this variable was dichotomized into two groups: those that did use LT and those that did not use LT.

Statistical Analyses

Multivariate analysis of variance was used to compare those that did use light therapy to those that did not use light therapy on dependent variables including total scores for processes of change, treatment credibility, outcome expectations, self-efficacy, social support, and depression symptoms, while controlling for age. The significance level was set at 0.05 for the study. Data analyses were conducted using SPSS 17.0 (SPSS Inc., Chicago, IL).

Results

Participants

Demographics.

A total of 40 individuals age 18 or older responded to the survey and met study inclusion criteria. Inclusion criteria were that individuals had to self-report that they have been diagnosed with a disorder for which light therapy is a treatment (i.e., SAD or MDD), and had to report that they had at least heard of light therapy as a treatment for their disorder. Participants reported diagnoses of Major Depressive Disorder With Seasonal Pattern (MDD-SP; n = 16, 38.1%), Bipolar I Disorder With Seasonal Pattern (n = 12, 28.6%), Bipolar II Disorder With Seasonal Pattern (n = 9, 21.4%), or Major Depressive Disorder without a seasonal pattern (MDD; n = 5, 11.9%). The number of individuals with a Bipolar Disorder With Seasonal Pattern did not differ across the groups using or not using light therapy, X2 (1, 42) = 0.48, p = .49. Similarly, the number of individuals reporting a seasonal pattern diagnosis (i.e., MDD-SP, and Bipolar I or II With Seasonal Pattern) did not differ between groups reporting use or non-use, X2 (1, 42) = .26, p = .67. Groups that did and did not use light therapy were also compared by race, age, and gender (Table 1). As the group reporting LT use was older, age was included as a covariate in the analysis. Overall, 17 out of 40 (42.5%) respondents reported using LT the previous winter.

thumbnail
Table 1. Demographic variables compared between those that did and did not use LT.

https://doi.org/10.1371/journal.pone.0039275.t001

Predictors of light therapy use.

In the omnibus MANOVA, the self-efficacy and social support scales were significantly associated with whether or not individuals reported using light therapy in the previous winter (Table 2 & Figure 1). Some other group differences were in the expected direction, albeit not significantly different across groups statistically (see Table 2).

thumbnail
Figure 1. Comparison of motivation, credibility, and depression symptom scale scores between those reporting use vs. non-use of light therapy (M, SD).

*p<.05. Each measure has a different scale and minimum/maximum values, and is only compared here between groups defined by self-reported use vs. non-use of light therapy. Use: Individuals who reported using LT. Non Use: Individuals reporting no use of LT in the previous winter.

https://doi.org/10.1371/journal.pone.0039275.g001

Discussion

Light therapy self-efficacy and social support were associated with self-report of light therapy use. These data suggest that self-efficacy and social support predict use of light therapy, just as they predict use of treatments or behavior change in other health conditions or other depression treatments. Other variables such as outcome expectations, processes of change, depression scores, and treatment credibility were not significantly different in those reporting light therapy use. Michalak et al. (2007) [11] found that treatment credibility and expectations for light therapy were not associated with adherence to light therapy in SAD, consistent with our findings. In that study, as well as ours, scores on the treatment expectations scale were high in relation to the maximum score possible on each scale. In our study, the group mean scores on treatment credibility approached the maximum possible score of 10 across all 5 items (Did use: M = 8.16, SD = 1.45; Didn't use: M = 8.37, SD = 1.76). Therefore, it appears that treatment credibility is high across both samples, and a ceiling effect may explain the lack of predicted association between treatment credibility and LT use.

The main limitation is that the sample used was a self-selected group of individuals that self-identified as having been diagnosed with a mood disorder for which LT is recommended, rather than a group of clinically diagnosed participants. However, means and standard deviations for the CES-D scores were 38.29 (10.90) for the group reporting light therapy use, and 45.82 (6.96) for the group reporting no use, indicating that individuals were reporting significant depression symptom frequency for the previous winter. Individuals in this study reported similar symptom levels to those with a diagnosed mood disorder (M = 38.1 for individuals in a mood episode) [32]. Because self-reported diagnosis may be inaccurate, future studies will include in-person structured clinical interviews for diagnosis.

Another limitation of this study is that only 42.5% of the respondents reported using light therapy, so our measures are predicting any amount of light therapy use, rather than degree of adherence to a light therapy prescription. Additionally, the present study did not measure factors associated with adherence to other medication or psychotherapy treatments for depression, such as intention and willingness. These constructs may overlap with those of process of change, treatment credibility, and outcome expectations. Intention and willingness are related but theoretically separate constructs of behavioral change that have been defined as follows. Willingness reflects how willing an individual would be to engage in a particular coping strategy if a friend or treatment provider suggested it [33]. On the other hand, the construct of intention reflects a person's intention to perform a specific behavior (e.g., “I intend to do X”) [34]. Multiple theories including cognitive attitude-behavior relations, models of health behavior, and goal theory all propose that one's intention to complete homework determines motivation and performance [see 35–38]. In a meta-analysis of studies measuring intention and behavior change, intention accounted for 28% of the variance in behavior [39]. Burns and Nolen-Hoeksema (1991) [40] found that willingness and homework compliance individually predicted clinical improvement in CBT for depression. Because the present study is retrospective, and interpretation of intent retrospectively would be difficult to interpret, we measured overall willingness to engage in coping strategies for depressed mood. Future studies could measure intention and willingness at the time of diagnosis of a mood disorder, before a trial of light therapy, if patients who had not previously been diagnosed could be recruited.

In some ways, it is surprising that individuals choose not to use light therapy given that side effects are generally mild [3], [41], and that the rationale linking seasonal recurrence to treatment with light seems credible [42]. However, we found that other factors besides low side effects and treatment credibility that may also be important, namely self-efficacy and social support. Therefore, interventions that manipulate these motivational, cognitive, and behavioral factors may increase LT use rates, such as Motivational Enhancement Therapy [43] or Motivational Interviewing [44]. These approaches have demonstrated efficacy for a variety of health and mental health conditions for which successful treatment requires complex and sustained behavior change [45]. Understanding the impact of thoughts and appraisals regarding symptoms and treatment on the decision to use LT could be used to inform cognitive-behavioral interventions to maximize LT use and improve treatment in mood disorders. Further measurement of cognitive behavioral predictors of LT use should be performed prospectively with participants who have undergone structured diagnostic interviews, to increase confidence in the relationships between self-efficacy and social support and the use of LT.

Author Contributions

Conceived and designed the experiments: KAR JAS. Performed the experiments: MAM NCE. Analyzed the data: KAR. Wrote the paper: KAR MAM JAS.

References

  1. 1. Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, et al. (2005) The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 162: 656–662.RN GoldenBN GaynesRD EkstromRM HamerFM Jacobsen2005The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence.Am J Psychiatry162656662
  2. 2. Tuunainen A, Kripke DF, Endo T (2004) Light therapy for non-seasonal depression (Cochrane Review). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd. A. TuunainenDF KripkeT. Endo2004Light therapy for non-seasonal depression (Cochrane Review). The Cochrane Library.Chichester, UK: John Wiley & Sons, Ltd
  3. 3. Schwartz PJ, Brown C, Wehr TA, Rosenthal NE (1996) Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program. Am J Psychiatry 153: 1028–1036.PJ SchwartzC. BrownTA WehrNE Rosenthal1996Winter seasonal affective disorder: a follow-up study of the first 59 patients of the National Institute of Mental Health Seasonal Studies Program.Am J Psychiatry15310281036
  4. 4. Rohan KJ, Roecklein KA, Lacy TJ, Vacek PM (2009) Winter depression recurrence one year after cognitive-behavioral therapy, light therapy, or combination treatment. Behav Ther 40: 225–38.KJ RohanKA RoeckleinTJ LacyPM Vacek2009Winter depression recurrence one year after cognitive-behavioral therapy, light therapy, or combination treatment.Behav Ther4022538
  5. 5. Terman M, Terman JS, Quitkin FM, McGrath PJ, Stewart JW, Rafferty B (1989) Light therapy for seasonal affective disorder: a review of efficacy. Neuropsychopharmacology 2: 1–22.M. TermanJS TermanFM QuitkinPJ McGrathJW StewartB. Rafferty1989Light therapy for seasonal affective disorder: a review of efficacy.Neuropsychopharmacology2122
  6. 6. Flory R, Ametepe J, Bowers B (2010) A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of Seasonal Affective Disorder. Psychiatry Res 177: 101–108.R. FloryJ. AmetepeB. Bowers2010A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of Seasonal Affective Disorder.Psychiatry Res177101108
  7. 7. Thase ME, Nierenberg AA, Vrijland P, van Oers HJ, Schutte AJ, Simmons JH (2010) Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. Int Clin Psychopharmacol 25: 189–198.ME ThaseAA NierenbergP. VrijlandHJ van OersAJ SchutteJH Simmons2010Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.Int Clin Psychopharmacol25189198
  8. 8. Lam RW, Lonn SL, Despiegel N (2010) Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis. Int Clin Psychopharmacol 25: 199–203.RW LamSL LonnN. Despiegel2010Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.Int Clin Psychopharmacol25199203
  9. 9. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, et al. (2008) Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. J Clin Psychiatry 69: 1404–1415.N. WatanabeIM OmoriA. NakagawaA. CiprianiC. Barbui2008Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.J Clin Psychiatry6914041415
  10. 10. Michalak EE, Hayes S, Wilkinson C, Hood K, Dowrick C (2002) Treatment compliance in light therapy: Do patients do as they say they do? J Affect Disord 68: 341–342.EE MichalakS. HayesC. WilkinsonK. HoodC. Dowrick2002Treatment compliance in light therapy: Do patients do as they say they do?J Affect Disord68341342
  11. 11. Michalak EE, Murray G, Wilkinson C, Dowrick C, Lam RW (2007) A pilot study of adherence with light treatment for seasonal affective disorder. Psychiatry Res 149: 315–320.EE MichalakG. MurrayC. WilkinsonC. DowrickRW Lam2007A pilot study of adherence with light treatment for seasonal affective disorder.Psychiatry Res149315320
  12. 12. Claxton AJ, Cramer J, Pierce C (2001) A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23: 1296–1310.AJ ClaxtonJ. CramerC. Pierce2001A systematic review of the associations between dose regimens and medication compliance.Clin Ther2312961310
  13. 13. DiMatteo MR, Lepper HS, Croghan TW (2000) Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160: 2101–2107.MR DiMatteoHS LepperTW Croghan2000Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.Arch Intern Med16021012107
  14. 14. Prochaska JO, Redding CA, Evers KE (1997) The Transtheoretical Model and Stages of Change. In: Glanz K, Lewis FM, Rimer BK, editors. JO ProchaskaCA ReddingKE Evers1997The Transtheoretical Model and Stages of Change.K. GlanzFM LewisBK Rimereds.Health Behavior and Health Education.San Francisco: Jossey-Bass Publishers. 60–84. San Francisco: Jossey-Bass Publishers. 60–84.
  15. 15. Wilson GT, Schlam TR (2004) The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders. Clin Psychol Rev 24: 361–378.GT WilsonTR Schlam2004The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders.Clin Psychol Rev24361378
  16. 16. Baundra A (1986) Social foundations of thought and action: a social cognitive theory. Englewood Cliffs, NJ: Prentice Hall. A. Baundra1986Social foundations of thought and action: a social cognitive theory.Englewood Cliffs, NJ: Prentice Hall
  17. 17. Stepnowsky CJ Jr, Marler MR, Ancoli-Israel S (2002) Determinants of nasal CPAP compliance. Sleep Med 3: 239–247.CJ Stepnowsky JrMR MarlerS. Ancoli-Israel2002Determinants of nasal CPAP compliance.Sleep Med3239247
  18. 18. Sirey JA, Bruce ML, Kales HC (2010) Improving antidepressant adherence and depression outcomes in primary care: The treatment initiation and participation (TIP) program. Am J Geriatr Psychiatry 18: 554–562.JA SireyML BruceHC Kales2010Improving antidepressant adherence and depression outcomes in primary care: The treatment initiation and participation (TIP) program.Am J Geriatr Psychiatry18554562
  19. 19. Mausbach BT, Moore R, Roesch S, Cardenas V, Patterson TL (2010) The relationship between homework compliance and therapy outcomes: an updated meta-analysis. Cognit Ther Res 34: 429–438.BT MausbachR. MooreS. RoeschV. CardenasTL Patterson2010The relationship between homework compliance and therapy outcomes: an updated meta-analysis.Cognit Ther Res34429438
  20. 20. Worthington EL (1986) Client compliance with homework directives during counseling. J Couns Psychol 33: 124–130.EL Worthington1986Client compliance with homework directives during counseling.J Couns Psychol33124130
  21. 21. Neimeyer RA, Kazantzis N, Kassler DM, Baker KD, Fletcher R (2008) Group cognitive behavioural therapy for depression outcomes predicted by willingness to engage in homework, compliance with homework, and cognitive restructuring skill acquisition. Cogn Behav Ther 37: 199–215.RA NeimeyerN. KazantzisDM KasslerKD BakerR. Fletcher2008Group cognitive behavioural therapy for depression outcomes predicted by willingness to engage in homework, compliance with homework, and cognitive restructuring skill acquisition.Cogn Behav Ther37199215
  22. 22. Yovel I, Safren SA (2007) Measuring homework relevance in psychotherapy: CBT for adult ADHD as an example. Cognit Ther Res 31: 385–399.I. YovelSA Safren2007Measuring homework relevance in psychotherapy: CBT for adult ADHD as an example.Cognit Ther Res31385399
  23. 23. Fishbein M, Triandis HC, Kanfer FH, Becker M, Middlestadt SE, Eichler A (2001) Factors influencing behavior and behavior change. In: Baum A, Revenson TA, Singer JE, editors. pp. 3–17.M. FishbeinHC TriandisFH KanferM. BeckerSE MiddlestadtA. Eichler2001Factors influencing behavior and behavior change.A. BaumTA RevensonJE Singer317eds.Handbook of Health Psychology.Mahwah, NJ: Lawrence Erlbaum. Mahwah, NJ: Lawrence Erlbaum.
  24. 24. Bandura A (1997) The anatomy of stages of change. Am J Health Promot 12: 8–10.A. Bandura1997The anatomy of stages of change.Am J Health Promot12810
  25. 25. Gyurcsik NC, Brawley LR, Spink KS, Glazebrook KE, Anderson TJ (2011) Is level of pain acceptance differentially related to social cognitions and behavior? The case of active women with arthritis. J Health Psychol 16: 530–539.NC GyurcsikLR BrawleyKS SpinkKE GlazebrookTJ Anderson2011Is level of pain acceptance differentially related to social cognitions and behavior? The case of active women with arthritis.J Health Psychol16530539
  26. 26. Marcus BH, Selby VC, Niaura RS, Rossi JS (1992) Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 63: 60–66.BH MarcusVC SelbyRS NiauraJS Rossi1992Self-efficacy and the stages of exercise behavior change.Res Q Exerc Sport636066
  27. 27. Prochaska JO (1984) Systems of psychotherapy: a transtheoretical analysis. JO Prochaska1984Systems of psychotherapy: a transtheoretical analysis.2nd ed.Pacific Grove, CA: Brooks-Cole. Pacific Grove, CA: Brooks-Cole.
  28. 28. Marcus BH, Rossi JS, Selby VC, Niaura RS, Abrams DB (1992) The stages and processes of exercise adoption and maintenance in a worksite sample. Health Psychol 11: 386–395.BH MarcusJS RossiVC SelbyRS NiauraDB Abrams1992The stages and processes of exercise adoption and maintenance in a worksite sample.Health Psychol11386395
  29. 29. Prochaska JO, Velicer WF, DiClemente CC, Fava J (1988) Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol 56: 520–528.JO ProchaskaWF VelicerCC DiClementeJ. Fava1988Measuring processes of change: applications to the cessation of smoking.J Consult Clin Psychol56520528
  30. 30. Borkovec TD, Nau SD (1972) Credibility of analogue therapy rationales. Journal of Behavior Therapy 3: 257–260.TD BorkovecSD Nau1972Credibility of analogue therapy rationales.Journal of Behavior Therapy3257260
  31. 31. Radloff L (1977) The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1: 385–401.L. Radloff1977The CES-D Scale: a self-report depression scale for research in the general population.Applied Psychological Measurement1385401
  32. 32. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ (1977) Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 106: 203–214.MM WeissmanD. SholomskasM. PottengerBA PrusoffBZ Locke1977Assessing depressive symptoms in five psychiatric populations: a validation study.Am J Epidemiol106203214
  33. 33. Burns DD, Shaw BF, Croker W (1987) Thinking styles and coping strategies of depressed women: an empirical investigation. Behav Res Ther 25: 223–225.DD BurnsBF ShawW. Croker1987Thinking styles and coping strategies of depressed women: an empirical investigation.Behav Res Ther25223225
  34. 34. Sheeran P, Abraham C (2003) Mediator of moderators: temporal stability of intention and the intention-behavior relation. Pers Soc Psychol Bull 29: 205–215.P. SheeranC. Abraham2003Mediator of moderators: temporal stability of intention and the intention-behavior relation.Pers Soc Psychol Bull29205215
  35. 35. Abraham C, Sheeran P, Johnston M (1989) From health beliefs to self-regulation: theoretical advances in the psychology of action control. Psychol Health 13: 569–591.C. AbrahamP. SheeranM. Johnston1989From health beliefs to self-regulation: theoretical advances in the psychology of action control.Psychol Health13569591
  36. 36. Austin JT, Vancouver JB (1996) Goal constructs in psychology: structure, process, and content. Psychol Bull 120: 338–375.JT AustinJB Vancouver1996Goal constructs in psychology: structure, process, and content.Psychol Bull120338375
  37. 37. Conner M, Norman P (1996) Body weight and shape control: examining component behaviours. Appetite 27: 135–150.M. ConnerP. Norman1996Body weight and shape control: examining component behaviours.Appetite27135150
  38. 38. Maddux JE (1996) Expectancies and the social-cognitive perspective: basic principles, processes, and variables. In: Kirsch I, editor. JE Maddux1996Expectancies and the social-cognitive perspective: basic principles, processes, and variables.I. KirschEd.How expectancies shape behavior.Washington, DC: American Psychological Association. 17–40. Washington, DC: American Psychological Association. 17–40.
  39. 39. Sheeran P (2002) Intention-behavior relations: a conceptual and empirical review. Eur Rev Soc Psychol 12: 1–36.P. Sheeran2002Intention-behavior relations: a conceptual and empirical review.Eur Rev Soc Psychol12136
  40. 40. Burns DD, Nolen-Hoeksema S (1991) Coping styles, homework compliance, and the effectiveness of cognitive-behavioral therapy. J Consult Clin Psychol 59: 305–311.DD BurnsS. Nolen-Hoeksema1991Coping styles, homework compliance, and the effectiveness of cognitive-behavioral therapy.J Consult Clin Psychol59305311
  41. 41. Pail G, Huf W, Pjrek E, Winkler D, Willeit M, et al. (2011) Bright-light therapy in the treatment of mood disorders. Neuropsychobiology 64: 152–162.G. PailW. HufE. PjrekD. WinklerM. Willeit2011Bright-light therapy in the treatment of mood disorders.Neuropsychobiology64152162
  42. 42. Murray G. Seasonality: the importance of longitudinal measurement (2001) Magnusson A, Partonen T, editors. Seasonal Affective Disorder: Practice and Research. New York: Oxford University Press. 55–62. measurement Murray G. Seasonality: the importance of longitudinal2001Magnusson A, Partonen T, editors. Seasonal Affective Disorder: Practice and Research.New York: Oxford University Press. 55–62
  43. 43. Aloia MS, Smith K, Arnedt JT, Millman RP, Stanchina M, et al. (2007) Brief behavioral therapies reduce early positive airway pressure discontinuation rates in sleep apnea syndrome: preliminary findings. Behav Sleep Med 5: 89–104.MS AloiaK. SmithJT ArnedtRP MillmanM. Stanchina2007Brief behavioral therapies reduce early positive airway pressure discontinuation rates in sleep apnea syndrome: preliminary findings.Behav Sleep Med589104
  44. 44. Miller WR, Rollnick S (2002) Motivational interviewing: preparing people for change. WR MillerS. Rollnick2002Motivational interviewing: preparing people for change.2nd ed.New York: Guilford Press. New York: Guilford Press.
  45. 45. Lundahl BW, Kunz C, Brownell C, Tollefson D, Burke BL (2010) A meta-analysis of motivational interviewing: twenty-five years of empirical studies. Res Soc Work Pract 20: 137–160.BW LundahlC. KunzC. BrownellD. TollefsonBL Burke2010A meta-analysis of motivational interviewing: twenty-five years of empirical studies.Res Soc Work Pract20137160